From Cilia to Circuits: Anthrobots and the Next Generation of Healing
Güncelleme tarihi: 13 Eyl 2025
Living microscopic robots built from human cells are no longer just science fiction.
Anthrobots have the potential to change not only biotechnology, but also how we understand and redesign living systems. But didn’t this journey actually begin with mechanical robot arms?
In fact, the term “anthrobot” was first used in 1990 by Mark E. Rosheim.
At that time, it described mechanical robots that could move like a human arm, with seven degrees of freedom.
So at first, anthrobot meant machines shaped like humans. But today, we use the same word to talk about fully living systems made of cells. This change happened not only because of technology, but also because of a deep scientific interest in redefining what life means.
In the last 20 years, scientists developed systems that can respond to the environment and even help tissues grow.
These systems often used biodegradable materials.But they were usually either fully artificial or had very limited biological functions. This is where anthrobots come in—as living, autonomous, and task-focused systems.
The first scientific definition of anthrobots came in 2023, from the work of Gizem Gümüşkaya and her team. They created anthrobots using human tracheal epithelial cells.
These tiny living structures (30–500 micrometers in size) had motile cilia—small hair-like parts that allowed them to move. The anthrobots in Gümüşkaya’s study could move by themselves, sense their environment, and even support nerve repair.
In lab experiments, they helped neurons grow new connections within just three days.
This showed that anthrobots could be active biological tools—not just passive carriers.
Gene analysis (transcriptomics) showed that these anthrobots expressed genes like early-stage embryos. Even their epigenetic age was found to be negative.
This means they were not only young in appearance, but also in molecular behavior.
They may benefit from the flexibility of early life stages. This kind of flexibility is one of the main things that separates anthrobots from traditional biomaterial systems.
How Can We Integrate Anthrobots with Biomaterials?
The goal is not just to use materials as carriers or passive release systems.
We need to design hybrid systems where anthrobots can interact with their surroundings and take action based on environmental conditions.This requires not only physical integration, but also functional cooperation. In these systems, biomaterials must act more like active interfaces—not just as platforms.
For example, stimuli-responsive hydrogels can release anthrobots at specific target sites.
Hydrogels made of alginate combined with metal–organic frameworks (MOFs) can break down in acidic or low-oxygen environments, such as tumor or damaged tissue.
This allows anthrobots to be released right where they are needed.Unlike classic drug delivery systems, this method enables controlled release of living, active agents—not just molecules.
Materials with dynamic covalent bonds—such as boronic ester-based hydrogels—can help anthrobots temporarily attach to tissues and detach in response to small pH changes.
This is possible because cell membranes naturally have diol groups, which can form reversible bonds with boronic acids at physiological pH. Such systems allow anthrobots to connect to or leave tissues when certain signals appear.
This is especially useful for tasks that require short-term, targeted interaction.
DNA–polymer hybrid systems can also be used to program anthrobot behavior.
For instance, DNA–cyclodextrin conjugates made via click chemistry can react to specific biochemical signals. This makes it possible to guide anthrobots not only physically, but also chemically. They can, for example, activate a task when they detect a specific DNA strand.
Such programmable interfaces allow anthrobots to receive “commands” from the environment.
Meanwhile, self-healing hydrogels can repair themselves after anthrobots pass through, keeping the tissue structure safe.
In all these cases, biomaterials are not just passive support systems. They become smart, responsive partners that act together with anthrobots based on the context.
From Micro-Movers to Micro-Medics: Where Can Anthrobots Actually Help?
At this point, the real question is no longer “how are anthrobots made,” but “where can we use them?”
In the future, anthrobots could be used in many fields—such as treating neurodegenerative diseases, delivering drugs to specific areas, repairing damaged tissues, and even targeting cancer microenvironments.
The interaction between anthrobots and nerve cells, shown in Gümüşkaya’s study, is especially important for regenerative medicine. This kind of interaction could bring hope for healing in cases like spinal cord injuries or diseases like Alzheimer’s, where nerve connections are lost. If anthrobots can be combined with materials that guide nerve growth, they could help us build more advanced solutions for nerve regeneration.
Also, anthrobots are very good at sensing their microenvironment. This makes them great candidates for smart drug delivery. Their surfaces can be functionalized to respond only in target tissues—for example, reacting to acidic pH or special enzymes found in tumor areas. In this way, anthrobots could start releasing drugs only when they reach the right place.
Some earlier studies mentioned in Gümüşkaya’s paper showed bio-robotic systems used in cancer environments. These systems were improved using surface modifications and crosslinking techniques. For example, smart polymer networks can be designed to respond to tumor enzymes like MMPs (matrix metalloproteinases), helping anthrobots become active only in cancerous tissues.
Similar strategies can also work in neurodegenerative diseases. Anthrobots can be made to respond to inflammation—so they would only activate in damaged or inflamed neural areas.
Another possible use is in tissue engineering. Anthrobots can serve as “living templates” to guide cell movement and tissue formation. They might help stem cells move to the right place, or support blood vessel growth. For example, in building muscle tissue, anthrobots could help align muscle cells. In cartilage engineering, they could guide cells to form a proper 3D structure.
In short, anthrobots are not just moving cell clusters. They are next-generation biological tools—designed for specific tasks, able to sense their environment, react to it, and even trigger healing processes when needed.
From Trachea to Brain: Can Other Cell Types Build Anthrobots Too?
At the center of all these exciting possibilities is the type of cells used to build anthrobots.
In Gümüşkaya’s study, human tracheal epithelial cells were used. These cells have motile cilia—tiny hair-like structures that move—and this gave the anthrobots the ability to move on their own.
But this leads to an important question:
Is this kind of movement only possible with this specific cell type?
Actually, other types of ciliated cells also exist. For example:
• Ependymal cells are found in the brain and help move cerebrospinal fluid using their cilia. However, these cells are difficult to keep alive and control in lab cultures.
• Fallopian tube epithelial cells also have motile cilia, helping to move the egg. But they have ethical and availability limitations.
• Bronchial epithelial cells, which help clean the airways using cilia, can be cultured more easily. But their structure and speed may be different.
So, we are not limited to tracheal cells when designing anthrobots.
Still, each cell type affects how the anthrobot behaves—its speed, direction, and what kind of task it can perform. This means choosing a different cell is not just a technical detail—it actually changes the whole function of the system.
But here’s another important point:
Can we make anthrobots without using cilia at all?
Yes—there are other types of cell movement we can use.
For example:
• Actin–myosin based contractions can help some cells crawl or slide.
These movements are slower than cilia, but they can still be guided.
• Muscle-like cells with tropomyosin expression can produce rhythmic contractions and be directed in certain ways.
• Dendritic cells, which are part of the immune system, can sense signals in their environment and move toward them.
This shows that anthrobots can be made using different movement strategies, not only cilia.
But each strategy comes with its own pros and cons.
Other factors also matter when choosing cells:
For example,
can the cells be grown in the lab?
Can they be produced in large numbers?
Can they be genetically programmed?
Are they safe to use in the body?
Some solutions may come from iPSC-derived cells (induced pluripotent stem cells), which can be made from a person’s own tissue. This opens the door to personalized anthrobots.
Even though cilia are a big advantage today, we may one day use other organelles, microfluidic structures, or synthetic biological motors to power new kinds of anthrobots.
Now, one essential question remains:
Are anthrobots just an exciting biological idea—or are they truly the beginning of a new class of systems that could transform medicine, technology, and even ethics?
The work by Gümüşkaya and her team gives us a strong answer.
They showed that structures made only from human cells can move with purpose, sense their environment, and even support nerve repair. These systems go beyond traditional bio-robots—they don’t just imitate life; they give us tools to rebuild and redesign it.
But to move forward, we need a new kind of engineering:
• New materials that don’t just carry the cells,
• But actually guide and support them—without limiting their natural behavior.
So what is the role of biomaterials researchers in this new world?
It’s clear:
We need to develop materials that can work with anthrobots, not just hold them.
We must go beyond the old idea of passive carriers or static scaffolds.
We need smart, responsive, biocompatible interfaces that can communicate with cells—possibly using chemical logic circuits, or other environmental cues.
This is more than just a scientific or technological change.
It’s a paradigm shift—one that blurs the line between engineering and life itself.
But here’s another interesting question:
Could we build anthrobot-like systems without cilia?
If movement can be created not by cilia, but by other biological systems—like:
• actin-driven cell migration,
• contractile microenvironments, or
• external-stimuli-based artificial muscles—
Then maybe we need to redefine what “anthrobot” really means.
Is it about movement?
Or is it about living, purposeful structure?
From a broader view, there may also be other cell types that can form cilia under special conditions.
For example:
• Some embryonic cells produce short-lived cilia after fertilization,
• And in some respiratory diseases, cilia overgrowth has been observed—
showing that we may be able to grow ciliated cells under controlled lab conditions.
So the biology is flexible—
We just need to combine that flexibility with smart engineering.
Anthrobots haven’t yet reached clinical use.
But they’ve already proven something big:
Life can be programmed.
And that program doesn’t live only in DNA !
-It’s in how cells behave together,
-How they interact with materials and environments,
-And how they make decisions on a microscale level.
Anthrobots are telling us something:
We can design life. But to do that,we must first truly understand it.
Because now,
We are not just designing materials—
We are engineering life.
REFERENCES
Gümüşkaya, G., Spector, J. A., Blackiston, D. J., Bronner, M. E., & Levin, M. (2023). Human-derived anthrobots from engineered organoid systems. Nature Nanotechnology, 18, 1007–1016. https://doi.org/10.1038/s41565-023-01577-y
Kriegman, S., Blackiston, D., Levin, M., & Bongard, J. (2020). A scalable pipeline for designing reconfigurable organisms. Proceedings of the National Academy of Sciences, 117(4), 1853–1859. https://doi.org/10.1073/pnas.1910837117
Kriegman, S., et al. (2021). Kinematic self-replication in reconfigurable organisms. Proceedings of the National Academy of Sciences, 118(49), e2022672118. https://doi.org/10.1073/pnas.2112672118
Blackiston, D., Lederer, E., Kriegman, S., Garnier, S., Bongard, J., & Levin, M. (2021). A cellular platform for the development of synthetic living machines. Science robotics, 6(52), eabf1571. https://doi.org/10.1126/scirobotics.abf1571
Nawroth, J. C., et al. (2012). A tissue-engineered jellyfish with biomimetic propulsion. Nature Biotechnology, 30(8), 792–797. https://doi.org/10.1038/nbt.2269
Park, S. J., et al. (2016). Phototactic guidance of a tissue-engineered soft-robotic ray. Science, 353(6295), 158–162. https://doi.org/10.1126/science.aaf4292
Miskin, M. Z., et al. (2020). Electronically integrated, mass-manufactured, microscopic robots. Nature, 584, 557–561. https://doi.org/10.1038/s41586-020-2626-9
Nasajpour, A., et al. (2023). Microrobots for biomedical applications: Current state and future perspectives. Advanced Functional Materials, 33(3), 2208154. https://doi.org/10.1021/acsnano.3c03723
Li, J., Esteban-Fernández de Ávila, B., Gao, W., Zhang, L., & Wang, J. (2017). Micro/Nanorobots for Biomedicine: Delivery, Surgery, Sensing, and Detoxification. Science robotics, 2(4), eaam6431. https://doi.org/10.1126/scirobotics.aam6431
Zarepour, A., Khosravi, A., Iravani, S., & Zarrabi, A. (2024). Biohybrid Micro/Nanorobots: Pioneering the Next Generation of Medical Technology. Advanced healthcare materials, 13(31), e2402102. https://doi.org/10.1002/adhm.202402102
Xue, L., An, R., Zhao, J., Qiu, M., Wang, Z., Ren, H., Yu, D., & Zhu, X. (2025). Self‐healing hydrogels: Mechanisms and biomedical applications. MedComm, 6(5). https://doi.org/10.1002/mco2.70181
Rosheim, M. E. (1990). Design of an Omnidirectional Arm. In Proceedings of the 1990 IEEE International Conference on Robotics and Automation (pp. 249–254). IEEE. https://doi.org/10.1109/ROBOT.1990.126418
Li Zhang, Jake J. Abbott, Lixin Dong, Bradley E. Kratochvil, Dominik Bell, Bradley J. Nelson; Artificial bacterial flagella: Fabrication and magnetic control. Appl. Phys. Lett. 9 February 2009; 94 (6): 064107. https://doi.org/10.1063/1.3079655



Yorumlar